It inhibits the PI3K/Akt/mTOR pathway [35,36] that is implicated in EAE and MS [37], and in an effective fashion prevents the development of a MIF-dependent immunoinflammamtory hepatitis in mice [34,38]. Here, AKT1 is linked to hepatitis A virus infection.